Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Product Description
Methotrexate 98% is a high-purity pharmaceutical active pharmaceutical ingredient (API) widely used in oncology, autoimmune disease treatment, and advanced drug formulation development. As an antimetabolite compound, it plays a critical role in inhibiting folate metabolism and is essential in chemotherapy and immunosuppressive therapies.
In the global pharmaceutical supply chain, Methotrexate is a key compound for GMP-certified manufacturing, Supplement Contract Manufacturing, and CDMO production systems. It is widely used in both injectable and oral dosage form development.
Content Note: Prepared by our technical team based on peer-reviewed scientific literature. This content is intended for industrial and research use only and complies with FDA/EFSA communication guidelines. Last reviewed: June 2026
According to a study in The New England Journal of Medicine (1988), methotrexate demonstrated significant efficacy in the management of rheumatoid arthritis as a disease-modifying antirheumatic drug.
According to a study in Journal of Clinical Oncology (2001), methotrexate-based regimens showed measurable therapeutic outcomes in selected oncology applications including lymphoma treatment protocols.
Methotrexate 98% is produced under strict GMP manufacturing systems to ensure consistent purity, stability, and pharmaceutical-grade quality for global distribution.
| Parameter | Specification |
|---|---|
| Active Ingredient | Methotrexate |
| Purity | ≥ 98% |
| Appearance | Yellow to orange crystalline powder |
| Test Method | HPLC |
| Form | API powder / pharmaceutical intermediate |
| Storage Condition | 2–8°C, sealed and protected from light |
The quality of Methotrexate 98% is highly dependent on synthesis control, purification technology, and GMP-certified production environments. Advanced processing ensures safety, consistency, and regulatory compliance.
| Process Stage | Impact on Product Quality |
|---|---|
| Controlled chemical synthesis | Ensures molecular consistency and therapeutic reliability |
| Multi-stage purification system | Reduces impurities and improves safety profile |
| Controlled drying and packaging | Enhances stability and shelf-life performance |
| API | Mechanism | Primary Use |
|---|---|---|
| Methotrexate | Folate metabolism inhibition | Autoimmune diseases, cancer therapy |
| Docetaxel | Microtubule stabilization | Solid tumor chemotherapy |
| Cyclophosphamide | DNA alkylation | Broad-spectrum oncology treatment |
Methotrexate 98% is widely used in pharmaceutical manufacturing and clinical drug development for oncology and immunology applications.
It is also applied in research involving Plant Extracts , Standardized Extracts, Herbal Extracts , Nutritional Ingredients, and Antioxidants for pharmaceutical innovation and formulation science.
We supply Methotrexate 98% under strict GMP-certified systems with full regulatory support for global pharmaceutical markets.
It is used as an active pharmaceutical ingredient for treating cancer and autoimmune diseases.
Yes, it is commonly processed into sterile injectable and oral dosage forms under GMP standards.
The standard purity is ≥98%, verified through HPLC testing methods.
It should be stored at 2–8°C in a sealed, light-protected environment to maintain stability.
Yes, we provide OEM, private label, and contract manufacturing services for global pharmaceutical clients.

Packaging & Delivery
The file is encrypted. Please fill in the following information to continue accessing it